Mouth Ulcers Treatments

Find Mouth Ulcers Treatments

Brand Name

Otezla

Generic Name
Apremilast
View Brand Information
FDA approval date: February 26, 2020
Classification: Phosphodiesterase 4 Inhibitor
Form: Tablet, Kit

What is Otezla (Apremilast)?

OTEZLA/OTEZLA XR, an inhibitor of phosphodiesterase 4 , is indicated for the treatment of: Adult patients with: Active psoriatic arthritis.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Background: Major depressive disorder (MDD) is a psychiatric condition. People with MDD have occasional bouts of depressive symptoms; these bouts are called major depressive episodes (MDEs). Researchers want to know if people having MDEs have lower levels of an enzyme called PDE4B in their brains. Primary

Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder

Summary: For this protocol, the investigators plan to collect data to evaluate apremilast (60mg/day) vs placebo in adults with Alcohol Use Disorders (AUD).

Human Laboratory Study of Apremilast for Alcohol Use Disorder

Summary: Primary: The primary objective of this study is to compare the efficacy of two different maintenance doses of apremilast (tablets) in reducing alcohol craving among subjects with moderate to severe alcohol use disorder (AUD) after two weeks of daily dosing. Secondary: Secondary objectives include evaluation of two different maintenance doses of apremilast compared with matched placebo on other mea...